Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

News

Surgery to treat chronic sinus disease more effective than antibiotics

Sinus surgery is more effective than antibiotics in treating chronic rhinosinusitis, according to a major clinical trial conducted by the Surgical Intervention Trials Unit (SITU) at the University of Oxford.

Major new study aims to improve surgery options for acid reflux patients

A UK-wide research team, led by the University of Oxford, has launched a major international study to improve surgical treatment for people suffering from gastro-oesophageal reflux disease (GORD), a chronic condition that affects around one in five adults in the UK.

Mr Tony Jefferis, Senior Teaching Fellow, Nuffield Department of Surgical Sciences, Oxford University

It is with great sadness that we announce the sad passing of Mr Tony Jefferis. Tony has been a very important part of Oxford education and in particular surgical education for over two decades.

Oxford University spinout OrganOx to be acquired by Terumo for a record $1.5bn

An agreement has been reached for the acquisition of OrganOx, a pioneering University of Oxford spinout transforming kidney and liver transplantation, by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion. The transaction, which is subject to regulatory and other approvals, would be the largest acquisition of an Oxford University spinout to date, and one of the most significant venture capital exits in UK university spinout history.